Arinna Lifesciences
Tracked across 3 events · 29 articles · First seen Apr 14, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Arinna Lifesciences was acquired by Rubicon Research for approximately INR 175.92 crore for an 85% stake. Its founder, Vivek Seth, will retain a 15% stake and continue as Managing Director, providing continuity and leveraging its existing network for Rubicon Research.
Apr 14, 2026 · 8 articles
Business
Impact: Arinna Lifesciences, a subsidiary of Parijat, will secure exclusive rights to use HELM branding in India, supporting the launch of new product lines.
Aug 17, 2026 · 6 articles
Business
Impact: Arinna Lifesciences has a collaboration with Molbio for cancer screening, but is not directly involved in the IPO.
Aug 05, 2026 · 15 articles
ERGEN INTELLIGENCE
Track Arinna Lifesciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard